Skip to main content
. Author manuscript; available in PMC: 2013 Oct 1.
Published in final edited form as: Spine (Phila Pa 1976). 2012 Oct 1;37(21):1791–1802. doi: 10.1097/BRS.0b013e3182634b04

Table 3.

Area under curve subgroup results from the adjusted* as-treated Oswestry Disability Index (ODI) outcome analysis for combinations of the six significant treatment effect predictors (time weighted average 4 year treatment effects).

N Surgical Non-operative Treatment Effect
(95% CI)
Non-smokers with ODI ≤ 56, foraminal
stenosis, neurological deficit, predominant
leg pain, and no lifting at work
35 −23.8 (2.7) 0.3 (3.1) −24.1 (−30.2, −18)
Smokers with ODI > 56 23 −0.9 (3.8) −4.5 (5.2) 3.6 (−5.6, 12.8)
Others 576 −20.2 (0.7) −9.9 (0.8) −10.2 (−12.1, −8.4)
p-value <0.001 0.003 <0.001
*

Adjusted for center, age, gender, baseline ODI score, income, treatment preference, duration of symptoms, compensation, smoking status, BMI, baseline Stenosis Bothersomeness, joint, stomach and bowel problems.

Treatment effect is the difference between the surgical and non-operative mean change from baseline. Analysis is done using a mixed model with a random subject intercept term. Treatment is a time-varying covariate where a patients’ experience prior to surgery is attributed to the non-operative arm and time is measured from enrollment and his/her post-surgery outcomes are attributed to the surgical arm and time is measured from time of surgery.